R. Bitonti, F. Demma, M. Rea, and G. Furneri, “Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test”, AboutOpen, vol. 9, no. 1, pp. 105–111, Nov. 2022.